Product Information
BUMETANIDE 2 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2357 per EA under NDC 68382052701. Its NADAC has been published 341 times since Sep 12, 2018.
The High Outlier badge above means this manufacturer's average price in the bumetanide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382052701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202900On Market Since
5/1/2018
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 2 MG TABLET has been published 341 times since Sep 12, 2018, and over the history we have for it it has declined 72.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2357 per EA |
|---|---|
| All-time high | $0.8973 (Jul 10, 2019) |
| All-time low | $0.2091 (Nov 20, 2024) |
| 52-week high | $0.2357 |
| 52-week low | $0.2357 |
| Median price | $0.4552 |
| Average price | $0.5040 |
| Largest weekly change | +35.6% (Jun 19, 2024) |
| Weeks tracked | 341 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUMETANIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2357 per EA (NDC 68382052701), effective Jul 2, 2025.
How has the price of BUMETANIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 72.6%. It has been tracked across 341 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?
Since Sep 12, 2018, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.2091 (Nov 20, 2024) to a high of $0.8973 (Jul 10, 2019), with a median of $0.4552 per EA.
Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUMETANIDE 2 MG TABLET, is $0.1749 per EA — about 26% below BUMETANIDE 2 MG TABLET.
Who manufactures BUMETANIDE 2 MG TABLET?
BUMETANIDE 2 MG TABLET (NDC 68382052701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification